Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Safeguarding nanovesicles and their payload: A framework for stable storage.

Colloids and surfaces. B, Biointerfaces·2026
Same author

Cathepsin Z/X: Breaking Down the Known and Unknown.

International journal of molecular sciences·2026
Same author

Decoy Nanoparticles and Protein Corona Modulation: A Novel Frontier in Sepsis Treatment.

International journal of nanomedicine·2026
Same author

Broad-acting antivirals: the pursuit of pan-viral therapeutics in the era of pandemics.

Journal of virology·2026
Same author

Understanding the Burden of Coinfection: COVID-19 in Hospitalized Patients with Diagnosed and Undiagnosed Advanced HIV.

Current HIV research·2026
Same author

Regional, Age, and Sex Patterns of Hepatitis C Virus Infection in Russia: Insights from a 42,000-Participant Serosurvey.

Viruses·2025

相关实验视频

Updated: May 20, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

10.9K

生物模拟纳米粒子用于基本药物输送.

Andrey Tikhonov1, Artyom Kachanov1, Alexandra Yudaeva1

  • 1Laboratory of Genetic Technologies, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.

Pharmaceutics
|October 26, 2024
PubMed
概括

仿生纳米粒子 (BMNPs) 模仿自然囊泡,以提供高效,生物相容的药物输送. 本综述涵盖了它们的准备,功能化以及临床使用的挑战.

关键词:
这是一个RNARNARNARNARNA.货物 货物 货物 货物 货物 货物运输车辆 运输车辆 运输车辆 运输车辆有针对性的交付目标.治疗药物 治疗药物

更多相关视频

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

15.7K
Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

7.4K

相关实验视频

Last Updated: May 20, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

10.9K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

15.7K
Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

7.4K

科学领域:

  • 生物材料科学 生物材料科学
  • 纳米技术 纳米技术
  • 药物输送系统 药物输送系统

背景情况:

  • 仿生纳米颗粒 (BMNPs) 利用自然的细胞外囊泡特性来进行先进的药物输送.
  • 与传统的纳米载体相比,它们提供了增强的生物相容性和降低的毒性.
  • BMNP可以封装治疗有效载荷并修改现有的纳米技术.

研究的目的:

  • 为生物模拟纳米粒子制备和功能化提供全面的概述.
  • 分析各种BMNP类型,包括细胞膜涂层纳米颗粒 (CMCNPs),人工细胞衍生囊泡 (ACDVs) 和全合成囊泡 (fSVs).
  • 讨论BMNP的大规模生产和临床翻译的挑战和解决方案.

主要方法:

  • 对"自上而下"和"自下而上"纳米粒子制造方法的审查.
  • 专注于诸如细胞膜涂层,货物装载和微流体制造等技术.
  • 对功能化策略进行分析,以提高治疗疗效.

主要成果:

  • BMNP显示出克服生物障碍和向特定器官/组织的潜力.
  • 用生物膜涂覆纳米粒子显著改善治疗结果.
  • 有各种方法可以为各种应用程序准备和功能化BMNPs.

结论:

  • 由于其固有的生物相容性和向能力,BMNP代表了药物输送技术的前沿.
  • 解决大规模制造和临床应用的挑战对于实现BMNP的全部潜力至关重要.
  • 对仿生技术的持续研究将推动纳米医学领域的创新.